Inovio Pharmaceuticals Inc (INO): Thurs 5/26/22 11:00 am ET INO-4800

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	3218
Boards Moderated	0
Alias Born	04/26/2007

Lakers_w

Re: None

Wednesday, 03/09/2022 3:30:41 PM

Wednesday, March 09, 2022 3:30:41 PM

Thurs 5/26/22 11:00 am ET INO-4800 – A DNA based Vaccine Against COVID-19
2nd Genetic Vaccine Development for Infectious Disease, Boston
Track B: Optimizing Clinical Translation & Development

Kate Broderick
Senior Vice President, R&D, INOVIO
Synopsis
Demonstrating efficacy in animal challenge models
Understanding phase 3 immunogenicity and safety profile
Proof of thermo stability of DNA vaccines and enhanced delivery through electroporation

Track A: Advancing Pre-Clinical Development & Discovery
11:00 am Optimizing DNA Vaccines Against Emerging Infectious Diseases

Ami Patel
Research Assistant Professor, The WISTAR Institute
Synopsis
Understanding DNA vaccine design and insight into mechanism of action
Demonstrating DNA vaccine preclinical studies
immunogenicity and protection in animal models
Understanding what constitutes next generation DNA vaccines and future outlook
https://genetic-vaccine-development.com/whats-on/day-two/